Neurosense Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Neurosense Therapeutics (NRSNW) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Neurosense Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Neurosense Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurosense Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $397 | 1.3k | 0.31 |
| 2025-06-30 | $931 | 1.5k | 0.63 |
| 2025-03-31 | $582 | 2.8k | 0.20 |
| 2024-12-31 | $41 | 94 | 0.44 |
| 2024-09-30 | $28 | 200 | 0.14 |
| 2024-06-30 | $124 | 605 | 0.21 |
| 2023-09-30 | $422 | 3.8k | 0.11 |
| 2022-12-31 | $127 | 798 | 0.16 |
| 2022-09-30 | $0 | 2.0k | 0.00 |
| 2021-12-31 | $4.0k | 4.5k | 0.89 |
Top funds holding Neurosense Therapeutics
View all funds holding Neurosense Therapeutics